This is a preprint.
Genetic risk factors modulate the association between physical activity and colorectal cancer
- PMID: 40951278
- PMCID: PMC12425077
- DOI: 10.21203/rs.3.rs-7350654/v1
Genetic risk factors modulate the association between physical activity and colorectal cancer
Abstract
Background: Physical activity (PA) is an established protective factor for colorectal cancer (CRC), but it is unclear if genetic variants modify this effect. To investigate this possibility, we conducted a genome-wide gene-PA interaction analysis.
Methods: Using logistic regression and two-step and joint tests, we analyzed interactions between common genetic variants across the genome and PA in relation to CRC risk. Self-reported PA levels were categorized as active (≥ 8.75 MET-h/wk) vs. inactive (< 8.75 MET-h/wk) and as study- and sex-specific quartiles of activity.
Results: PA had an overall protective effect on CRC (OR [active vs. inactive] = 0.85; 95%CI = 0.81-0.90). The two-step GxE method identified an interaction between rs4779584, an intergenic variant near the GREM1 and SCG5 genes, and PA for CRC risk (p-interaction = 2.6×10- 8). Stratification by genotype at this locus showed a significant reduction in CRC risk by 20% in active vs. inactive participants with the CC genotype (OR = 0.80; 95%CI = 0.75-0.85), but no significant PA-CRC association among CT or TT carriers. When PA was modeled as quartiles, the 1-d.f. GxE test identified that rs56906466, an intergenic variant near the KCNG1 gene, modified the association between PA and CRC (p-interaction = 3.5×10- 8). Stratification at this locus showed that increase in PA (highest vs. lowest quartile) was associated with a lower CRC risk solely among TT carriers (OR = 0.77; 95%CI = 0.72-0.82).
Conclusions: In summary, we identified two genetic variants that modified the association between PA and CRC risk. One of them, related to GREM1 and SCG5, suggests that the bone morphogenetic protein (BMP)-related, inflammatory, and/or insulin signaling pathways may be associated with the protective influence of PA on colorectal carcinogenesis.
Keywords: GWAS; colorectal cancer; gene-environment interaction; physical activity.
Conflict of interest statement
Dr. Ulrich has as HCI Cancer Center Director oversight over research funded by several pharmaceutical companies but has not received funding directly herself. Dr. Peters was a consultant with AbbVie and her husband is holding individual stocks for the following companies: BioNTech SE - ADR, Amazon, CureVac BV, NanoString Technologies, Google/Alphabet Inc Class C, NVIDIA Corp, Microsoft Corp. Other authors declare that they have no conflict of interest.
Figures
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021, 71(3):209–249. - PubMed
-
- Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F: Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017, 66(4):683–691. - PubMed
-
- Sawicki T, Ruszkowska M, Danielewicz A, Niedzwiedzka E, Arlukowicz T, Przybylowicz KE: A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers (Basel) 2021, 13(9).
-
- World Cancer Research Fund/American Institute for Cancer Research. Continous Update Project Expert Report 2018. Diet, nutrition, physical activity and colorectal cancer. Available at dietandcancerreport.org. In.
Publication types
Grants and funding
- 75N92021D00005/WH/WHI NIH HHS/United States
- P30 CA015704/CA/NCI NIH HHS/United States
- P30 DK034987/DK/NIDDK NIH HHS/United States
- U24 CA074794/CA/NCI NIH HHS/United States
- U01 CA164930/CA/NCI NIH HHS/United States
- U01 CA167551/CA/NCI NIH HHS/United States
- R01 CA201407/CA/NCI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- U01 CA122839/CA/NCI NIH HHS/United States
- P01 CA196569/CA/NCI NIH HHS/United States
- U19 CA148107/CA/NCI NIH HHS/United States
- R01 CA059045/CA/NCI NIH HHS/United States
- 75N92021D00002/HL/NHLBI NIH HHS/United States
- R01 CA197350/CA/NCI NIH HHS/United States
- R01 CA076366/CA/NCI NIH HHS/United States
- R35 CA197735/CA/NCI NIH HHS/United States
- R01 CA072520/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- R01 CA273198/CA/NCI NIH HHS/United States
- K05 CA154337/CA/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- S10 OD028685/OD/NIH HHS/United States
- R01 CA151993/CA/NCI NIH HHS/United States
- U01 CA167552/CA/NCI NIH HHS/United States
- R01 CA048998/CA/NCI NIH HHS/United States
- U01 CA137088/CA/NCI NIH HHS/United States
- R01 CA066635/CA/NCI NIH HHS/United States
- R21 CA191312/CA/NCI NIH HHS/United States
- R01 CA244588/CA/NCI NIH HHS/United States
- 75N92021D00001/HL/NHLBI NIH HHS/United States
- R01 CA137178/CA/NCI NIH HHS/United States
- U01 CA074794/CA/NCI NIH HHS/United States
- P30 CA014089/CA/NCI NIH HHS/United States
- R01 CA081488/CA/NCI NIH HHS/United States
- R01 CA063464/CA/NCI NIH HHS/United States
- P01 CA033619/CA/NCI NIH HHS/United States
- 75N92021D00003/WH/WHI NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- R01 CA060987/CA/NCI NIH HHS/United States
- T32 ES013678/ES/NIEHS NIH HHS/United States
- U01 CA074783/CA/NCI NIH HHS/United States
- U01 CA084968/CA/NCI NIH HHS/United States
- R37 CA054281/CA/NCI NIH HHS/United States
- 75N92021D00004/WH/WHI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous
